ArticleNews reportPHN-05682026-11-01 23:00 CT

Weekly Recap: Wegovy scripts 265k+ and injunction denied in Eli Lilly ad suit

Source · TradingView

TLDR

TradingView’s recap reports that U.S. weekly Wegovy prescriptions exceeded 265,000 by mid-July. It also reports that a U.S. judge denied Novo Nordisk’s request to block Eli Lilly advertisements while false-advertising litigation continues.

01—Key points

01The judge found Novo Nordisk had not demonstrated irreparable harm warranting a preliminary injunction.
02The recap reports Novo Nordisk launched oral Wegovy in France without reimbursement.
03TradingView labels the recap AI-generated and warns it may contain inaccuracies.

Why it matters Editorial

The recap highlights prescription volume, market expansion and ongoing advertising litigation involving Novo Nordisk’s obesity-treatment business.

Read the original at TradingView↗

Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.